-
Posted by
Two Blokes May 20 -
Filed in
Stock
-
0 views
Launches Campaign Website at www.CureMediPharm.com , Which Articulates 5-Pillar Plan to Rebuild Company Details How MediPharm Labs is Hemorrhaging Money at an Alarming Rate and is on Pace to Run Out of Cash by November 2025 Exorbitant Executive Compensation Packages Despite Persistent Losses Demonstrate a Board and Management Team Misaligned with Shareholders' Best Interests Board Cannot Be Trusted After Costing Shareholders $1 Billion Nominates Six Highly Qualified Director Candidates – John Fowler, Alan D. Lewis, David Lontini, Demetrios Mallios, Regan McGee, and Scott Walters – to Cure MediPharm Labs Before It's Too Late Nominees Bring Significant Turnaround, M&A, and Operational Expertise Alongside Fresh Perspectives to Restore Value and Accountability at MediPharm Labs URGES SHAREHOLDERS TO DISREGARD MEDIPHARM'S GREEN PROXY CARD AND VOTE THE GOLD PROXY CARD "FOR" APOLLO CAPITAL'S SIX DIRECTOR NOMINEES TORONTO , May 20, 2025 /PRNewswire/ -- Apollo Technology Capital Corporation ("Apollo Capital"), which together with its affiliates and associates collectively is one of the largest shareholders of MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs", or the "Company"), owning approximately 3.0% of the Company's common stock, today announced that it has filed an amended and restated information circular (the "Circular") in connection with its intention to nominate six highly qualified director candidates to MediPharm's Board of Directors (the "Board") at the Company's upcoming 2025 Annual and Special Meeting of Shareholders to be held on June 16, 2025 (the "Annual Meeting").
